- GROUP Survivorship
- PROJECT SPAN 2022
- DATE 17/10/2022
Rebecca Venchiarutti
COSA's Survivorship Fellowship program was established in 2020 to help build capacity in survivorship research. Fellows receive mentorship, guidance and support from the Survivorship Executive Committee comprised of internationally renowned senior clinicians and researchers in cancer survivorship. Dr Rebecca Venchiarutti was one of four Survivorship Fellows appointed in 2022. Prof Bogda Koczwara was her primary mentor.
Fellowship Project
Priorities for multimorbidity management and research in cancer: a Delphi study of Australian cancer survivors, clinicians, and researchers
Purpose
Multimorbidity is common in people with cancer and associated with increased complexity of care, symptoms, mortality, and costs. This study aimed to identify priorities for care and research for cancer survivors with multimorbidity.
Methods
A Delphi consensus process was conducted. Elements of care and research were based on Australia’s National Strategic Framework for Chronic Conditions, a literature review, and expert input. In Round 1, health professionals, cancer survivors, and researchers rated the importance of 18 principles, 9 enablers, and 4 objectives. In Round 2, new elements were rated and all elements were ranked.
Results
In Round 1, all elements reached consensus for care delivery; three principles and one enabler did not reach consensus for research and were eliminated. One principle and two enablers were added, reaching consensus. In the final list, 19 principles, 10 enablers, and 4 objectives were included under care delivery; 14 principles, 9 enablers, and 4 objectives were included under research. For care delivery, principles of ‘survivorship’ and ‘self-management’ were ranked highest, and ‘peer support’ and ‘technology’ were the most important enablers. For research, ‘survivorship’ and ‘coordinated care’ were the highest-ranked principles, with ‘peer support’ and ‘education’ the most important enablers.
Conclusion
Most elements apply to the general population and cancer survivors; however, additional elements relevant to survivorship need consideration when managing multimorbidity in cancer survivors.
Implications for Cancer Survivors
Chronic disease frameworks should be more inclusive of issues prioritised by people with, managing, or researching cancer through interdisciplinary approaches including acute and primary care.
Venchiarutti, R.L., Dhillon, H., Ee, C. et al. Priorities for multimorbidity management and research in cancer: a Delphi study of Australian cancer survivors, clinicians, and researchers. J Cancer Surviv (2024). https://doi.org/10.1007/s11764-024-01686-0
Related projects
Survivorship
Patient Reported Outcomes (PRO) Working Group
Survivorship
Financial Toxicity Working Group
Survivorship
Survivorship Fellow - Gemma McErlean
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 5 days ago
Our March member newsletter is out now. Check your inbox for COSA news, events, resources, journal articles and more. Or read it online anytime at Not receiving it? Login to the new COSA member system and update your preferences. pic.
Read More >
COSAoncology 12 days ago
Earlybird closes on Sunday 22 March! A weekend of engaging and interactive workshops and lively discussion. For cancer pharmacists at all stages of their careers. Earn 10+ self-report CPD points. Gain insights you can apply immediately in practice. pic.
Read More >
COSAoncology 14 days ago
Arrangements are well underway for our 2026 COSA ASM at the ICC Sydney in November. The ASM website is now live and we encourage you to submit your work for consideration in the program in a submitted symposium or as an oral or poster presentation. #COSA26 pic.
Read More >
COSAoncology 24 days ago
Cancer pharmacists, register now for this 2-day intensive course. Advanced Stream offerings include AI in Cancer Pharmacy, BiTE updates & Cardio-Oncology. Junior Pharmacists jump start your knowledge & skills in lymphoma, breast, lung & colorectal cancer. pic.
Read More >
COSAoncology one month ago
Cancer pharmacists, have you registered for this 2-day intensive course in Melbourne in May? With Foundation & Advanced Streams to suit pharmacists at all levels. Access earlybird & COSA member discounts Not a member? Join to save pic.
Read More >
COSAoncology one month ago
Our February member newsletter is out now. Check your inbox for COSA news, events, resources, journal articles and more. Or read it online anytime at Not receiving it? Login to the new COSA member system and update your preferences. pic.
Read More >
COSAoncology one month ago
An unmissable opportunity for cancer pharmacists at all levels! Learn new skills, build on your existing knowledge, network and grow your career. Register today to secure your place. Save on your registration with earlybird and COSA member discounts. pic.
Read More >
COSAoncology one month ago
RT by @cosaoncology: Don't miss your chance to give your research a place in the global spotlight & help accelerate progress in cancer care. Submit your abstract to 2026 ASCO Breakthrough today! The deadline for submission is 2 weeks away—Feb. 24 at 11:59 pm (ET): #ASCOBT26 pic.
Read More >
COSAoncology one month ago
For World Cancer Day, COSA and CNSA have released a joint position statement on the contribution of nurses to cancer survivorship care in Australia, with recommendations for strengthening survivorship care nationally. Read more pic.
Read More >
COSAoncology 2 months ago
Our January member newsletter is out now. Check your inbox for COSA news, group updates, affiliate events, resources, journal articles and more. Or read it online anytime at pic.
Read More >